What Tysabri treats
Tysabri (natalizumab) is a biologic medication used to treat multiple sclerosis (MS) and Crohn’s disease. It is indicated for patients with relapsing forms of multiple sclerosis and for those with moderate to severe Crohn’s disease who have not responded adequately to other treatments. Tysabri works by targeting and inhibiting alpha-4 integrin, a protein involved in the inflammatory process.
Benefits of Tysabri
Patients using Tysabri often experience significant benefits, including reduced frequency of MS relapses, decreased disease activity, and improved overall function in multiple sclerosis. For Crohn’s disease patients, Tysabri helps to manage gastrointestinal symptoms and induce remission. The intravenous infusion schedule allows for effective long-term management of these chronic conditions with regular monitoring of patient response.
Possible Side Effects of Tysabri
While Tysabri is generally effective, some patients may experience side effects, including infusion-related reactions such as fever, chills, and nausea. Other potential side effects include headache, fatigue, and gastrointestinal issues like abdominal pain. Serious side effects, although rare, can include an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and potentially severe brain infection. It is important to monitor for any adverse effects and report them to your healthcare provider.
How infusion works at Prime
Tysabri is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Tysabri, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
How Does Tysabri Work?
Tysabri works by binding to alpha-4 integrin, a protein found on the surface of white blood cells. This binding prevents these cells from migrating to the central nervous system (CNS) or the intestines, thereby reducing inflammation and damage in multiple sclerosis and Crohn’s disease. By inhibiting alpha-4 integrin, Tysabri helps to control the inflammatory response and manage symptoms associated with these chronic conditions. Tysabri is administered through intravenous infusion, typically given every four weeks.
Who is Tysabri For?
Tysabri is suitable for adults with relapsing forms of multiple sclerosis who have not responded adequately to other disease-modifying therapies. It is also prescribed for adults with moderate to severe Crohn’s disease who require additional treatment to manage their condition. Tysabri is recommended for individuals who need targeted therapy to reduce inflammation and improve their symptoms.